These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2188897)

  • 21. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
    Rumble JR; Doyle AE; Cooper ME
    Am J Hypertens; 1995 Jan; 8(1):53-7. PubMed ID: 7734098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes.
    Emonnot L; Cohen R; Lo M
    Am J Hypertens; 2008 Jun; 21(6):657-62. PubMed ID: 18443571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
    Björck S; Aurell M
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of continuous subcutaneous insulin infusion on renal morphology in experimental diabetes. I. Blood glucose levels, body size, kidney weight and glomerulotubular morphometry.
    Mayhew TM; Sharma AK; McCallum KN
    J Pathol; 1987 Feb; 151(2):147-55. PubMed ID: 3572611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps.
    Clermont AC; Brittis M; Shiba T; McGovern T; King GL; Bursell SE
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):981-90. PubMed ID: 8125761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulated hepatic insulin gene therapy of STZ-diabetic rats.
    Thulé PM; Liu JM
    Gene Ther; 2000 Oct; 7(20):1744-52. PubMed ID: 11083496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of vanadate on in vivo myocardial reactivity to norepinephrine in diabetic rats.
    Paulson DJ; Kopp SJ; Tow JP; Peace DG
    J Pharmacol Exp Ther; 1987 Feb; 240(2):529-34. PubMed ID: 3543300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats.
    Hartmann JF; Szemplinski M; Hayes NS; Keegan ME; Slater EE
    J Hypertens; 1988 Aug; 6(8):677-83. PubMed ID: 2846685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension in experimental diabetes mellitus. Renin-prostaglandin interaction.
    Katayama S; Lee JB
    Hypertension; 1985; 7(4):554-61. PubMed ID: 3891614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat.
    Kalinyak JE; Sechi LA; Griffin CA; Don BR; Tavangar K; Kraemer FB; Hoffman AR; Schambelan M
    J Am Soc Nephrol; 1993 Dec; 4(6):1337-45. PubMed ID: 8130360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin treatment reduces the increased serum and lung angiotensin converting enzyme activity in streptozotocin-induced diabetic rats.
    Erman A; Chen-Gal B; David I; Giler S; Boner G; van Dijk DJ
    Scand J Clin Lab Invest; 1998 Feb; 58(1):81-7. PubMed ID: 9516660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of the renin-angiotensin system in streptozotocin-diabetic rats.
    Cassis LA
    Am J Physiol; 1992 Jan; 262(1 Pt 1):E105-9. PubMed ID: 1733240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure reduction in hypertensive-diabetic rats by the somatostatin analog MK-678.
    Hartmann J; Szemplinski M; Chen SL; Slater E
    Life Sci; 1989; 45(3):267-74. PubMed ID: 2569653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Food intake in diabetic rats: relationship to metabolic effects of insulin treatment.
    Friedman MI; Ramirez I
    Physiol Behav; 1994 Aug; 56(2):373-8. PubMed ID: 7938252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin-angiotensin system and prostacyclin biosynthesis in streptozotocin diabetic rats.
    Funakawa S; Okahara T; Imanishi M; Komori T; Yamamoto K; Tochino Y
    Eur J Pharmacol; 1983 Oct; 94(1-2):27-33. PubMed ID: 6360695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of streptozotocin-induced diabetes and insulin treatment on blood pressure in the male rat.
    Katovich MJ; Hanley K; Strubbe G; Wright BE
    Proc Soc Exp Biol Med; 1995 Mar; 208(3):300-6. PubMed ID: 7878070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous long-term insulin delivery in diabetic rats utilizing implanted osmotic minipumps.
    Lopaschuk GD; Tahiliani AG; McNeill JH
    J Pharmacol Methods; 1983 Feb; 9(1):71-5. PubMed ID: 6843141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on stable control of blood sugar by continuous administration of insulin through isolated intestinal loop].
    Saito H; Mashima Y; Tashiro T; Yamamori H; Horibe K; Nishizawa M; Okui K
    Nihon Geka Gakkai Zasshi; 1992 Jan; 93(1):16-25. PubMed ID: 1372385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.